Morgan Stanley’s Perspective Therapeutics CATX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.58M Buy
1,623,388
+64,937
+4% +$223K ﹤0.01% 3974
2025
Q1
$3.32M Buy
1,558,451
+414,989
+36% +$884K ﹤0.01% 4262
2024
Q4
$3.65M Buy
1,143,462
+858,061
+301% +$2.74M ﹤0.01% 4260
2024
Q3
$3.81M Buy
285,401
+133,505
+88% +$1.78M ﹤0.01% 4174
2024
Q2
$1.51M Buy
151,896
+74,460
+96% +$742K ﹤0.01% 4735
2024
Q1
$921K Buy
77,436
+66,043
+580% +$786K ﹤0.01% 4995
2023
Q4
$45.8K Buy
11,393
+5,696
+100% +$22.9K ﹤0.01% 6411
2023
Q3
$15.6K Sell
5,697
-518
-8% -$1.42K ﹤0.01% 6561
2023
Q2
$41.5K Sell
6,215
-909
-13% -$6.07K ﹤0.01% 6285
2023
Q1
$45.5K Sell
7,124
-1,279
-15% -$8.16K ﹤0.01% 6324
2022
Q4
$20.8K Hold
8,403
﹤0.01% 6683
2022
Q3
$19K Sell
8,403
-3
-0% -$7 ﹤0.01% 6815
2022
Q2
$26K Sell
8,406
-657
-7% -$2.03K ﹤0.01% 6882
2022
Q1
$33K Buy
9,063
+1,440
+19% +$5.24K ﹤0.01% 6897
2021
Q4
$30K Buy
7,623
+1
+0% +$4 ﹤0.01% 7039
2021
Q3
$48K Hold
7,622
﹤0.01% 6743
2021
Q2
$61K Buy
7,622
+7,402
+3,365% +$59.2K ﹤0.01% 6584
2021
Q1
$2K Hold
220
﹤0.01% 7255
2020
Q4
$1K Buy
+220
New +$1K ﹤0.01% 6936
2020
Q2
Sell
-100
Closed -$1K 6607
2020
Q1
$1K Sell
100
-47
-32% -$470 ﹤0.01% 6450
2019
Q4
$1K Hold
147
﹤0.01% 6553
2019
Q3
$0 Hold
147
﹤0.01% 6640
2019
Q2
$1K Hold
147
﹤0.01% 6523
2019
Q1
$1K Hold
147
﹤0.01% 6504
2018
Q4
$0 Hold
147
﹤0.01% 6602
2018
Q3
$1K Hold
147
﹤0.01% 6612
2018
Q2
$1K Hold
147
﹤0.01% 6580
2018
Q1
$1K Buy
147
+47
+47% +$320 ﹤0.01% 6527
2017
Q4
$0 Buy
+100
New ﹤0.01% 6571
2015
Q4
Sell
-1,040
Closed -$14K 6672
2015
Q3
$14K Sell
1,040
-758
-42% -$10.2K ﹤0.01% 6153
2015
Q2
$26K Buy
1,798
+978
+119% +$14.1K ﹤0.01% 6061
2015
Q1
$13K Sell
820
-13,572
-94% -$215K ﹤0.01% 6162
2014
Q4
$210K Buy
14,392
+12,848
+832% +$187K ﹤0.01% 5214
2014
Q3
$26K Buy
1,544
+724
+88% +$12.2K ﹤0.01% 5924
2014
Q2
$25K Sell
820
-573
-41% -$17.5K ﹤0.01% 5969
2014
Q1
$31K Buy
+1,393
New +$31K ﹤0.01% 5851